Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-156541

Kite Pharma, Inc. · KITE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Arie Belldegrun
Officer — Chairman, President and CEO · Director
Period of report
Dec 20, 2016
Accepted (ET)
Dec 22, 2016 · 4:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 20, 2016S3,493$50.86D24,707D
Common StockF2holding———1,673,750ISee footnote
Common StockF3holding———159,329ISee footnote
Common StockF4holding———430,190ISee footnote
Common StockF5holding———500,000ISee footnote
Common StockF6holding———500,000ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses